This post was originally published on this site
https://i-invdn-com.investing.com/trkd-images/LYNXMPEH7I0I7_L.jpg
(Reuters) – Kohl’s Corp (NYSE:KSS) beat quarterly sales estimates on Thursday as the department store chain, like rival Macy’s Inc (NYSE:M), benefited from Americans returning to brick-and-mortar stores, following the roll out of COVID-19 vaccines.
Net sales rose to $4.22 billion from $3.21 billion in the second quarter ended July 31, compared with analysts’ estimates of $4.02 billion, according to IBES data from Refinitiv.